Exact Mass: 648.6209
Exact Mass Matches: 648.6209
Found 188 metabolites which its exact mass value is equals to given mass value 648.6209,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CE(18:2(9Z,12Z))
Cholesteryl linoleic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl linoleate is contained in low density lipoprotein and atherosclerotic lesions. The oxidation products of cholesteryl linoleate may cause chronic inflammatory processes. (PMID 9684755, 11950694) [HMDB] Cholesteryl linoleic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl linoleate is contained in low density lipoprotein and atherosclerotic lesions. The oxidation products of cholesteryl linoleate may cause chronic inflammatory processes. (PMID 9684755, 11950694). Cholesteryl linoleate is shown to be the major cholesteryl ester contained in LDL and atherosclerotic lesions.
Cholest-5-en-3-ol (3beta)-, (9Z,12Z)-9,12-octadecadienoate
CHOLESTERYL LINOLEATE
Cholesteryl linoleate is shown to be the major cholesteryl ester contained in LDL and atherosclerotic lesions.
[17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] octadeca-9,12-dienoate
hexadecyl 2-methylprop-2-enoate,octadecyl 2-methylprop-2-enoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tricosanoate
[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate
(1-hydroxy-3-pentadecoxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (Z)-pentadec-9-enoate
[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate
[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] (Z)-heptadec-9-enoate
(1-hydroxy-3-tridecoxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate
[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-nonadec-9-enoate
(1-hydroxy-3-undecoxypropan-2-yl) (17Z,20Z)-octacosa-17,20-dienoate
(1-hydroxy-3-octadecoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-heptadecoxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
(1-docosoxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-hydroxy-3-tricosoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] tridecanoate
[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-icos-11-enoate
[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexacos-15-enoate
[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-docos-13-enoate
[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] heptadecanoate
[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonadecanoate
(1-hydroxy-3-icosoxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentadecanoate
[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] icosanoate
[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] henicosanoate
(1-hydroxy-3-nonadecoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetracos-13-enoate
[1-hydroxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] undecanoate
[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] octadecanoate
[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] docosanoate
(1-henicosoxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-hexadec-7-enoate
[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11E,14E)-heptadeca-11,14-dienoate
[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-heptadec-7-enoate
[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4E,7Z)-hexadeca-4,7-dienoate
[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,12Z)-octadeca-9,12-dienoate
[(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-octadec-9-enoate
cholesteryl octadecadienoate
A cholesterol ester in which the acyl group contains 18 carbons and 2 double bonds.
